HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- Wall St set to slip as US-Iran tensions cloud start to second half
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil falls as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Boeing commercial jet deliveries and production disrupted by widespread IT outage - Air Current
HealthEquity, Inc (HQY) PT Raised to $98 at Oppenheimer
March 19, 2019 9:30 AM EDTOppenheimer analyst Mohan Naidu raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $98.00 (from $74.00) while maintaining a Outperform rating.
The analyst commented, "HQY wrapped up the year at the higher end of the pre-released FY19 numbers at revenue/adj. EPS of... More
HealthEquity (HQY) Tops Q4 EPS by 5c, FY EPS Guidance Misses
March 18, 2019 4:08 PM EDTHealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $75.8 million versus the consensus estimate of $74.09 million.
GUIDANCE:
HealthEquity sees FY2020 EPS of $1.23-$1.29, versus the consensus of $1.31. HealthEquity sees... More
